Aclaris Therapeutics (ACRS) Share-based Compensation (2014 - 2026)
Aclaris Therapeutics (ACRS) reported Share-based Compensation of $2.67 million for Q2 2026, down 12.8% from $3.06 million a year earlier and down 16.4% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aclaris Therapeutics' Share-based Compensation came in at $11.66 million, down 6.5% year-over-year; for FY2025, it came in at $12.38 million, up 14.1% from FY2024.
- Share-based Compensation has a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $10.86 million in FY2024 (-47.2%), $20.54 million in FY2023 (+36.6%), $15.04 million in FY2022 (+7.0%) and $14.06 million in FY2021 (+25.5%).
- The Q2 2026 figure ranks as the lowest quarterly Share-based Compensation since Q1 2024.
- Year over year, Share-based Compensation gained in four of the last eight quarters, with growth averaging 15.8%.
- The high point for year-over-year Share-based Compensation in five years was Q1 2023 (growth of 190.1%); the low point was Q4 2023 (a decline of 73.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $3.2 million (Q1 2026), $2.93 million (Q4 2025) and $2.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | 3.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.02 Mn |
| Jun 30, 2026 | 2.67 Mn |
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 3.06 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 5.95 Mn |
| Jun 30, 2023 | 6.52 Mn |
| Mar 31, 2023 | 6.81 Mn |
| Dec 31, 2022 | 4.81 Mn |
| Sep 30, 2022 | 4.19 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 3.85 Mn |
API Access
Aclaris Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();